Published DateClear

Start Date

End Date

Category

• Pipeline3
• Products1

Organizations

• Bausch + Lomb66
• Eyes On Eyecare51
• Alcon, Inc.46
• American Optometric Association37
• Harrow30
• Glaukos27
• Topcon Healthcare25
• Regeneron24
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• IOP4
• Glaucoma4
• Clinical Trials3
• Technology2
• FDA1
• Finance1
• Glaucoma Management1
• Medical Device1

• Organizations: Myra Vision✕

Clear all

Pipeline

First patient treated with Calibreye System in IDE glaucoma study

The ADAPT trial is evaluating Myra Vision’s next-gen aqueous shunt drainage device for optimizing IOP reduction in patients undergoing glaucoma surgery.

Pipeline

FDA green lights Myra Vision's IDE study for glaucoma

IDE approval enables company to initiate the open-label ADAPT study on its proprietary Calibreye TGT Surgical System.

Products

Myra Vision initiates FIH trial on Calibreye System for IOP reduction

Novel technology is being evaluated for use in open-angle glaucoma patients.

Pipeline

Myra Vision secures $25M for advancement of novel glaucoma treatment

The Shifamed portfolio company’s Calibreye System targets IOP reduction.